menu
    • menu

    Company profile for Organogenesis

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care, and surgical and sports medicine markets.Our mission is to provide an integrated portfolio of healing solutions that improve lives while lowering the overall cost of health care. We are relentless in the pursuit of quality and innovations that make all t...
    Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care, and surgical and sports medicine markets.Our mission is to provide an integrated portfolio of healing solutions that improve lives while lowering the overall cost of health care. We are relentless in the pursuit of quality and innovations that make all the difference.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OrganogenesisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    85 Dan Rd, Canton, Massachusetts, 02021
    Telephone
    Telephone
    (781) 575-0775
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://organogenesis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Organogenesis Completes BLA Submission for ReNu
    Organogenesis Completes BLA Submission for ReNu

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3283231/0/en/organogenesis-completes-rolling-submission-of-biologics-license-application-for-renu.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Organogenesis Plans BLA Filing For Renu For Knee Osteoarthritis
    Organogenesis Plans BLA Filing For Renu For Knee Osteoarthritis

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268753/0/en/Organogenesis-Announces-Successful-FDA-Meeting-and-Plan-to-File-BLA-for-ReNu-for-Knee-Osteoarthritis-Pain.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Organogenesis Holdings To Report Q1 FY2026 Financial Results
    Organogenesis Holdings To Report Q1 FY2026 Financial Results

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268357/0/en/Organogenesis-Holdings-Inc-to-Report-First-Quarter-of-Fiscal-Year-2026-Financial-Results-on-May-7-2026.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Organogenesis Meets Primary Endpoint In PuraplyAM Trial
    Organogenesis Meets Primary Endpoint In PuraplyAM Trial

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268773/0/en/Organogenesis-Achieves-Primary-Endpoint-in-Randomized-Controlled-Trial-of-PuraPly-AM.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Organogenesis to Report Q4 FY25 Results Feb. 26, 2026
    Organogenesis to Report Q4 FY25 Results Feb. 26, 2026

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241525/0/en/Organogenesis-Holdings-Inc-to-Report-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results-on-February-26-2026.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Organogenesis Initiates Biologics License Application For Renu
    Organogenesis Initiates Biologics License Application For Renu

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3210135/0/en/Organogenesis-Announces-Initiation-of-Biologics-License-Application-for-ReNu.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search